Similar articles

• Comparative disposition kinetics of albendazole in sheep following oral and intraruminal administration.

  Swarnkar CP, Sanyal PK, Singh D, Khan FA, Bhagwan PS. Swarnkar CP, et al. Vet Res Commun. 1998 Dec;22(8):545-51. doi: 10.1023/a:1006145820818. Vet Res Commun. 1998. PMID: 10066128
• Effect of single and divided dose administration on the pharmacokinetics of albendazole in sheep and goat.

  Sanyal PK. Sanyal PK. Vet J. 1998 May;155(3):311-6. doi: 10.1016/s1090-0233(05)80028-0. Vet J. 1998. PMID: 9638078
• Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.

  Capece BP, Castells G, Pérez F, Arboix M, Cristòfol C. Capece BP, et al. Vet Res Commun. 2000 Jul;24(5):339-48. doi: 10.1023/a:1006496122684. Vet Res Commun. 2000. PMID: 10868551
• Comparative pharmacokinetics and bioavailability of albendazole sulfoxide in sheep and goats, and dose-dependent plasma disposition in goats.

  Aksit D, Yalinkilinc HS, Sekkin S, Boyacioğlu M, Cirak VY, Ayaz E, Gokbulut C. Aksit D, et al. BMC Vet Res. 2015 May 27;11:124. doi: 10.1186/s12917-015-0442-5. BMC Vet Res. 2015. PMID: 26012791 Free PMC article.
• Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers.

  Rigter IM, Schipper HG, Koopmans RP, van Kan HJ, Frijlink HW, Kager PA, Guchelaar HJ. Rigter IM, et al. Antimicrob Agents Chemother. 2004 Mar;48(3):1051-4. doi: 10.1128/AAC.48.3.1051-1054.2004. Antimicrob Agents Chemother. 2004. PMID: 14982808 Free PMC article. Clinical Trial.